BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37513948)

  • 1. Innovative Delivery and Release Systems for Antioxidants and Other Active Substances in the Treatment of Cancer.
    Sezgin-Bayindir Z; Losada-Barreiro S; Fernández-Bravo S; Bravo-Díaz C
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant Therapy in Cancer: Rationale and Progress.
    Luo M; Zhou L; Huang Z; Li B; Nice EC; Xu J; Huang C
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts to fight oxidative stress: nanosized three-dimensional supramolecular antioxidant assemblies.
    Richard PU; Duskey JT; Stolarov S; Spulber M; Palivan CG
    Expert Opin Drug Deliv; 2015; 12(9):1527-45. PubMed ID: 25882382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry of Antioxidants: Mechanisms and Pharmaceutical Applications.
    Losada-Barreiro S; Sezgin-Bayindir Z; Paiva-Martins F; Bravo-Díaz C
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS).
    Rehman FU; Shah KU; Shah SU; Khan IU; Khan GM; Khan A
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1325-1340. PubMed ID: 27485144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.
    Handa M; Beg S; Shukla R; Barkat MA; Choudhry H; Singh KK
    J Control Release; 2021 Dec; 340():48-59. PubMed ID: 34695523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-Based Nano Systems for Natural Antioxidants in Breast Cancer Therapy.
    Herdiana Y; Husni P; Nurhasanah S; Shamsuddin S; Wathoni N
    Polymers (Basel); 2023 Jul; 15(13):. PubMed ID: 37447598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic drug delivery systems--recent advances.
    Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
    Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutraceutics and delivery systems.
    Shoji Y; Nakashima H
    J Drug Target; 2004 Jul; 12(6):385-91. PubMed ID: 15545088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.
    Bhalani DV; Nutan B; Kumar A; Singh Chandel AK
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review.
    Teixeira S; Carvalho MA; Castanheira EMS
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising strategies for improving oral bioavailability of poor water-soluble drugs.
    Rocha B; de Morais LA; Viana MC; Carneiro G
    Expert Opin Drug Discov; 2023 Jun; 18(6):615-627. PubMed ID: 37157841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing bioaccessibility and bioavailability of carotenoids using emulsion-based delivery systems.
    Boonlao N; Ruktanonchai UR; Anal AK
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112211. PubMed ID: 34800865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrin-based delivery systems in parenteral formulations: A critical update review.
    Ferreira L; Campos J; Veiga F; Cardoso C; Paiva-Santos AC
    Eur J Pharm Biopharm; 2022 Sep; 178():35-52. PubMed ID: 35868490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
    Ratnam DV; Ankola DD; Bhardwaj V; Sahana DK; Kumar MN
    J Control Release; 2006 Jul; 113(3):189-207. PubMed ID: 16790290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment.
    Attia M; Essa EA; Zaki RM; Elkordy AA
    Antioxidants (Basel); 2020 Apr; 9(5):. PubMed ID: 32344912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
    Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
    Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.